Correlation Between Genfit and Erytech Pharma
Can any of the company-specific risk be diversified away by investing in both Genfit and Erytech Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genfit and Erytech Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genfit and Erytech Pharma SA, you can compare the effects of market volatilities on Genfit and Erytech Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genfit with a short position of Erytech Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genfit and Erytech Pharma.
Diversification Opportunities for Genfit and Erytech Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Genfit and Erytech is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Genfit and Erytech Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erytech Pharma SA and Genfit is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genfit are associated (or correlated) with Erytech Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erytech Pharma SA has no effect on the direction of Genfit i.e., Genfit and Erytech Pharma go up and down completely randomly.
Pair Corralation between Genfit and Erytech Pharma
If you would invest 369.00 in Genfit on December 29, 2024 and sell it today you would lose (2.00) from holding Genfit or give up 0.54% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Genfit vs. Erytech Pharma SA
Performance |
Timeline |
Genfit |
Erytech Pharma SA |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Genfit and Erytech Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Genfit and Erytech Pharma
The main advantage of trading using opposite Genfit and Erytech Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genfit position performs unexpectedly, Erytech Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erytech Pharma will offset losses from the drop in Erytech Pharma's long position.Genfit vs. Day One Biopharmaceuticals | Genfit vs. Mirum Pharmaceuticals | Genfit vs. Rocket Pharmaceuticals | Genfit vs. Avidity Biosciences |
Erytech Pharma vs. Genfit | Erytech Pharma vs. HCW Biologics | Erytech Pharma vs. Aptorum Group Ltd | Erytech Pharma vs. Surrozen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |